$FIP FIP's stock price rose after the company announced its $1.05 billion acquisition of Wheeling & Lake Erie Railway. #Stocks

$EQ Equillium Announces Up to $50 Million in Private Placement Financing to Advance Clinical Development of EQ504 #Stocks

$NRXP NRx announced that the FDA granted Fast Track designation to NRX-100 (preservative-free intravenous ketamine) for the treatment of depression with suicidal ideation, expanding the potential market to 13 million patients in the United States (a 10-fold increase).#Stocks

$SBET The company projects revenue of $75 million to $90 million in 2025 and targets revenue of $225 million to $240 million in 2026, demonstrating confidence in future growth.#Stocks

$OSRH The price continues to rise and has broken through $1. Let's see its subsequent performance. I will continue to pay attention. #Stocks

$CAPS Capstone added $11 million in revenue through the acquisition of Carolina Stone, and its stock price rose 20%.#Stocks

$STSS Today's gains, driven by a $50 million SoloGard supply agreement and Hungarian plant upgrades, have pushed the stock price soaring to $11.35. #Stocks

$INHD Please stay tuned, if the stock price can hold above $4 and break through $6.167, it may rise further to $10. #Stocks

$IBKR The company is a large-cap growth stock with solid fundamentals, benefiting from customer growth, technological innovation, and global expansion. Its current share price is $65.21, up 94.76% over the past year. #Stocks

$IVVD High Growth Potential: Revenue growth (420.58%) far exceeds the industry average, demonstrating strong demand for the company's COVID-19 antibody market. Institutional ownership of 70.36% of the stock demonstrates market confidence in its long-term prospects.#Stocks

$SATS Current stock price: $29.88 (as of the close of August 25, the pre-market price was $51.60, up 72.69%). I will continue to pay attention to this stock. #Stocks

$OPAD OPAD has recently gained popularity among retail investors due to its "meme stock" phenomenon. Current share price: $4.38, up approximately 20.19% from the previous day's closing price of $3.64. #Stocks

$ALLR Allarity Therapeutics (ALLR) is a high-risk, high-reward biotech company whose stock price has recently shown significant short-term gains (up 98% in the past month). #Stocks

$RR It showed strong short-term upward momentum on August 26, 2025, with an intraday increase of approximately 30.25%, a medium-term (1 month) increase of approximately 58.92%, and a long-term (1 year) increase of approximately 148%. #Stocks

$STSS The stock price recently showed strong short-term upward momentum due to major private equity financing and progress in commercial orders. On August 27, the stock price reached US$16.182, with a significant intraday increase. #Stocks

Some fans expressed regret for not joining the WhatsApp stock group, missing out on the opportunity to buy $STSS, $NBY, and $INHD, ultimately failing to profit. My WhatsApp: 🚨wajump.com/1168 Join the group and reply "6" to invite you! Our profits are still growing!

I'm sharing a detailed investment plan for $STSS, $MDB, and $INHD in my WhatsApp group. Followers can access it for free. My WhatsApp: ✅ wajump.com/1168 After adding me, text "1" and I'll invite you. Our returns continue to soar, so don't miss any stock buy alerts! 🚨

$SNOW The August 2025 price target represents a 75.5% increase from the August 2024 price of $114.23. Based on 35 analyst forecasts, SNOW has a "Strong Buy" rating with a highest target price of $440. #Stocks

$NVDA I will continue to monitor the stock and recommend investors pay close attention to the August 27th earnings report and management's comments on future guidance. Strong financial performance will affect the stock's ups and downs. #Stocks